Stocks and Investing Stocks and Investing
Tue, June 18, 2024

Derek Archila Downgraded (ZNTL) to Hold and Decreased Target to $9 on, Jun 18th, 2024


Published on 2024-10-28 11:59:26 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Downgraded "Zentalis Pharmaceuticals, Inc." (ZNTL) to Hold and Decreased Target from $29 to $9 on, Jun 18th, 2024.

Derek has made no other calls on ZNTL in the last 4 months.



There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, all agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Robert Driscoll of "Wedbush" Maintained at Hold with Increased Target to $15 on, Wednesday, February 28th, 2024
Contributing Sources